Physician profile
Arlo J Reimer
NPI 1487625596
$211.24
in general payments reported to CMS, 2019-2025
9 companies · $18.71 in 2025
The $18.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.88 · 2020: $14.66 · 2021: $14.68 · 2023: $16.12 · 2024: $51.19 · 2025: $18.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $67.35 | 2021-2024 | |
| Novo Nordisk INC | $41.80 | 2019-2020 | |
| Viatris Specialty LLC | $18.71 | 2025 | Yupelri |
| Mylan Specialty L.P. | $15.28 | 2019 | |
| Pfizer INC. | $14.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.64 | 2024 | |
| Allergan, INC. | $14.46 | 2019 | |
| Lilly USA, LLC | $12.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlo Reimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.